156) nflammatory diseases, such as Alzheimer's disease (AD) and traumatic brain injury (T |
157) ve been found in up to 57% of Alzheimer's disease (AD) cases, most often in a limbic |
158) ved in the preclinical stage of Alzheimer disease (AD) cross-sectionally and have be |
159) Sporadic Alzheimer's disease (AD) exclusively affects elderly p |
160) Alzheimer's disease (AD) is a genetically complex, mul |
161) Alzheimer's disease (AD) is associated with inner reti |
162) sment of the central model of Alzheimer's disease (AD) pathogenesis, according to wh |
163) L1 gene, is a major player in Alzheimer's disease (AD) pathophysiology. |
164) Transgenic rodent models of Alzheimer's disease (AD) were designed to study mechan |
165) er (BBB) and is implicated in Alzheimer's disease (AD). |
166) creases risk for late-onset Alzheimer’s disease (AD). |
167) avior can predict preclinical Alzheimer's disease (AD). |
168) ctively examine the dietary acculturation-disease risk relationship in East Asian im |
169) iting from heterozygous to homozygous for disease risk alleles or non-risk alleles u |
170) c Lateral Sclerosis, not only influencing disease risk but are differentially expres |
171) Correlation analysis revealed novel IA disease risk factors which we used to deve |
172) r policies aimed at reducing diet-related disease risk in East Asian immigrant popul |
173) ncluding vectors of EEEV, which may alter disease risk posing a public health concer |
174) by which the GWAS variant contributes to disease risk. |
175) r knowledge of genetic factors underlying disease risk. |
176) try, and influences smoking cessation and disease risk. |
177) uration) may contribute to this increased disease risk. |
178) new therapeutic strategies for preventing disease progression and reducing tooth los |
179) ain miR-195 levels are reduced along with disease progression from normal aging to e |
180) deleterious association found with HIV-1 disease progression in South African adult |
181) However, to establish disease progression markers, it is essenti |
182) tion and function in normal cells and in disease progression such as with cancer. |
183) d treatment, led to a reduced TAA-induced disease progression with less severe fibro |
184) ariants underlying PAH susceptibility and disease progression. |
185) neration; hence it can be used to monitor disease progression. |
186) us erythematosus is a systemic autoimmune disease that affects the central nervous s |
187) teine protease released during injury and disease that can activate PAR2. |
188) ternatives to antimicrobials to treat the disease that can be applied in cow-calf op |
|